PubMed

Immunohistochemical localisation of intravitreally injected bevacizumab at the posterior pole of the primate eye: implication for the treatment of retinal vein occlusion.

Julien S, Heiduschka P, Hofmeister S, Schraermeyer U.

Br J Ophthalmol. 2008 Oct;92(10):1424-8.PMID: 18815425 [PubMed - indexed for MEDLINE]Related articles

Immunohistochemical localisation of intravitreally injected bevacizumab in the anterior chamber angle, iris and ciliary body of the primate eye.

Peters S, Heiduschka P, Julien S, Bartz-Schmidt KU, Schraermeyer U.

Br J Ophthalmol. 2008 Apr;92(4):541-4. Epub 2008 Jan 22.PMID: 18211933 [PubMed - indexed for MEDLINE]Related articles

Penetration of bevacizumab through the retina after intravitreal injection in the monkey.

Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, Schraermeyer U; Tübingen Bevacizumab Study Group.

Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2814-23.PMID: 17525217 [PubMed - indexed for MEDLINE]Related articlesFree article

Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.

Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU; Tübingen Bevacizumab Study Group, Schraermeyer U.

Am J Ophthalmol. 2007 Jun;143(6):995-1002. Epub 2007 Apr 23.PMID: 17449002 [PubMed - indexed for MEDLINE]Related articles

[Localisation of bevacizumab in the monkey retina after an intravitreal injection of Avastin]

Schraermeyer U, Heiduschka P, Bartz-Schmidt KU.

Ophthalmologe. 2009 Jul;106(7):619-24. German. PMID: 18781309 [PubMed - indexed for MEDLINE]Related articles

Treatment of branch retinal vein occlusion induced macular edema with bevacizumab.

Abegg M, Tappeiner C, Wolf-Schnurrbusch U, Barthelmes D, Wolf S, Fleischhauer J.

BMC Ophthalmol. 2008 Sep 29;8:18.PMID: 18823536 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.

Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ.

Graefes Arch Clin Exp Ophthalmol. 2008 Sep;246(9):1241-7. Epub 2008 Jun 11.PMID: 18546006 [PubMed - indexed for MEDLINE]Related articles

Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model.

Bakri SJ, Cameron JD, McCannel CA, Pulido JS, Marler RJ.

Am J Ophthalmol. 2006 Jul;142(1):162-4.PMID: 16815270 [PubMed - indexed for MEDLINE]Related articles

Early bevacizumab treatment of central retinal vein occlusion.

Ferrara DC, Koizumi H, Spaide RF.

Am J Ophthalmol. 2007 Dec;144(6):864-71. Epub 2007 Oct 4.PMID: 17916320 [PubMed - indexed for MEDLINE]Related articles

Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.

Kriechbaum K, Michels S, Prager F, Georgopoulos M, Funk M, Geitzenauer W, Schmidt-Erfurth U.

Br J Ophthalmol. 2008 Apr;92(4):518-22. Epub 2008 Jan 22.PMID: 18211942 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion.

Kreutzer TC, Alge CS, Wolf AH, Kook D, Burger J, Strauss R, Kunze C, Haritoglou C, Kampik A, Priglinger S.

Br J Ophthalmol. 2008 Mar;92(3):351-5. Epub 2008 Jan 22.PMID: 18211925 [PubMed - indexed for MEDLINE]Related articles

Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.

Batioğlu F, Astam N, Ozmert E.

Int Ophthalmol. 2008 Feb;28(1):59-61. Epub 2007 Jul 4.PMID: 17609852 [PubMed - indexed for MEDLINE]Related articles

Spectral domain OCT documented resolution of recalcitrant macular edema after intravitreal bevacizumab in branch retinal vein occlusion.

Chalam KV, Keshavamurthy R, Brar VS.

Eur J Ophthalmol. 2008 Sep-Oct;18(5):831-3.PMID: 18850569 [PubMed - indexed for MEDLINE]Related articles

Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study.

Moschos MM, Moschos M.

Doc Ophthalmol. 2008 Mar;116(2):147-52. Epub 2008 Jan 10.PMID: 18189152 [PubMed - indexed for MEDLINE]Related articles

Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin).

Shahar J, Avery RL, Heilweil G, Barak A, Zemel E, Lewis GP, Johnson PT, Fisher SK, Perlman I, Loewenstein A.

Retina. 2006 Mar;26(3):262-9.PMID: 16508424 [PubMed - indexed for MEDLINE]Related articles

Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans.

Krohne TU, Eter N, Holz FG, Meyer CH.

Am J Ophthalmol. 2008 Oct;146(4):508-12. Epub 2008 Jul 17.PMID: 18635152 [PubMed - indexed for MEDLINE]Related articles

Testing intravitreal toxicity of bevacizumab (Avastin).

Manzano RP, Peyman GA, Khan P, Kivilcim M.

Retina. 2006 Mar;26(3):257-61.PMID: 16508423 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for branch retinal vein occlusion.

Spandau U, Wickenhäuser A, Rensch F, Jonas J.

Acta Ophthalmol Scand. 2007 Feb;85(1):118-9. No abstract available. PMID: 17244225 [PubMed - indexed for MEDLINE]Related articles

Bevacizumab (avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice.

Heiduschka P, Julien S, Hofmeister S, Bartz-Schmidt KU, Schraermeyer U.

Retina. 2008 Jan;28(1):46-55.PMID: 18185137 [PubMed - indexed for MEDLINE]Related articles

The treatment of branch retinal vein occlusion with bevacizumab.

Badalà F.

Curr Opin Ophthalmol. 2008 May;19(3):234-8. Review.PMID: 18408499 [PubMed - indexed for MEDLINE]Related articles